Other Clinical Trial - Feeding Study in VLBW Premature Infants

See also
Status	Clinical Trial	Phase
Completed	`NCT03884322` - Self Regulated Physical Activity and Bone Growth Enhancement in Premature Infants	N/A
Recruiting	`NCT03775785` - Targeted vs Standard Fortification of Breast Milk	N/A
Completed	`NCT05224921` - Peripherel Perfusion Index to Predict Sepsis in Very Low Birth Weight Infants
Recruiting	`NCT04246333` - Duodenal Feeds in Very Low Birth Weight Infants	N/A

See also

Status

Clinical Trial

Phase

Completed

NCT03884322 - Self Regulated Physical Activity and Bone Growth Enhancement in Premature Infants

N/A

Recruiting

NCT03775785 - Targeted vs Standard Fortification of Breast Milk

N/A

Completed

NCT05224921 - Peripherel Perfusion Index to Predict Sepsis in Very Low Birth Weight Infants

Recruiting

NCT04246333 - Duodenal Feeds in Very Low Birth Weight Infants

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT05744193
Study type	Interventional
Source	Mead Johnson Nutrition
Contact	Nancy Moore, RD
Phone	812-429-5000
Email	nancy.moore@reckitt.com
Status	Not yet recruiting
Phase	N/A
Start date	May 15, 2023
Completion date	December 2024

Feeding Study in VLBW Premature Infants

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms